GE Healthcare Technologies Inc (NASDAQ:GEHC) reported second-quarter sales of $4.84 billion, flat year over year and up 1% organically, with positive price and volume. However, it marginally missed the consensus of $4.87 billion. Net income attributable to GE HealthCare was $428 million compared to $418 million the prior year, and Adjusted EBIT was $742 million compared to $711 million. Total company book-to-bill, defined as Total orders divided by Total revenues, was solid at 1.06 times. Total company orders increased 3% organically year-over-year. The company posted an ...